Analysis of the expression levels of surviving and VEGF in patients with acute lymphoblastic leukemia

Experimental and Therapeutic Medicine

Volumn 5, Issue 1, 2013, Pages 305-307

  Yang, Man ^a   Liu, Yongqiang ^a   Lu, Shufang ^a   Wang, Zhifen ^a   Wang, Ran ^a   Zi, Youmei ^a   Li, Jingdong ^a  

^a The First Affliated Hospital of Xinxiang Medical University   (China)

Author keywords

Acute lymphoblastic leukemia; Expression; Surviving; Vascular endothelial growth factor

Indexed keywords

CYTOSINE; ETOPOSIDE; IDARUBICIN; MESSENGER RNA; SURVIVIN; VASCULOTROPIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84869386876     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.769     Document Type: Article

References (15)

1. Altieri DC and Marchisio PC: Surviving apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 79: 1327-1333, 1999.
2. Ferrara N, Gerber HP and LeCouter J: The biology of VEGF and its receptors. Nat Med 9: 669-676, 2003.
3. Choi J and Chang H: The expression of MAGE and SSX, and correlation of COX2, VEGF, and survivin in colorectal cancer. Anticancer Res 32: 559-564, 2012.
4. Suzuki A, Hayashida M, Ito T, Kawano H, Nakano T, Miura M, Akahane K and Shiraki K: Surviving initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene 19: 3225-3234, 2000.
5. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR and Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964-3968, 1995.
6. Toi M, Inada K, Suzuki H and Tominaga T: Tumour angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 36: 193-204, 1995.
7. Guenova ML, Balatzenko GN, Nikolova VR, Spassov BV and Konstantinov SM: An anti-apoptotic pattern correlates with multidrug resistance in acute myeloid leukemia patients: a comparative study of active caspase-3, cleaved PARPs, Bcl-2, Surviving and MDR1 gene. Hematology 15: 135-143, 2010.
8. Redaelli A, Laskin BL, Stephens JM, Botteman MF and Pashos CL: A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur J Cancer Care (Engl) 14: 53-62, 2005.
9. Pui CH, Campana D, Pei D, et al: Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360: 2730-2741, 2009.
10. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC and Altieri DC: Control of apoptosis and mitotic spindle checkpoint by surviving. Nature 396: 580-584, 1998.
11. Altieri DC: Surviving in apoptosis control and cell cycle regulation in cancer. Prog Cell Cycle Res 5: 447-452, 2003.
12. Esh AM, Atfy M, Azizi NA, El Naggar MM, Khalil EE and Sherief L: Prognostic signifcance of surviving in pediatric acute lymphoblastic leukemia. Indian J Hematol Blood Transfus 27: 18 -25, 2011.
13. Morrison DJ, Hogan LE, Condos G, et al: Endogenous k nockdown of surviving improves chemotherapeutic response in ALL models. Leukemia 26: 271-279, 2012.
14. Ma W, Yao X, Tang F, et al: Regulation of pathway of survivin-NF-κB of leukemia HL60/adr cells by Jiedu Huayu Fang. J Beijing Univ Tradit Chin Med 35: 25-28, 2012 (In Chinese).
15. Demacq C, Vasconcellos VB, Izidoro-Toledo TC, et al: Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL). Clin Chim Acta 411: 1335-1340, 2010.